Literature DB >> 14102078

THE TUMOR-INHIBITORY EFFECTS OF THE METHYLHYDRAZINE DERIVATIVE RO 4-6467/1 (NSC-77213).

W BOLLAG.   

Abstract

Entities:  

Keywords:  ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; HYDRAZINES; MICE; NEOPLASMS, EXPERIMENTAL; PHARMACOLOGY; RATS; SARCOMA 180, CROCKER; UTERINE NEOPLASMS

Mesh：

Substances：

Year:  1963        PMID： 14102078

Source DB:  PubMed          Journal:  Cancer Chemother Rep        ISSN： 0069-0112


× No keyword cloud information.
  5 in total

Review 1.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

2.  Carcinogenicity of procarbazine.

Authors:  C Deckers; L Deckers-Passau; J Maisin; J M Gauthier; F Mace
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

3.  Methylazo and methylazoxy compounds; new types of antitumour agents.

Authors:  W Bollag; A Kaiser; A Langemann; P Zeller
Journal:  Experientia       Date:  1964-09-15

4.  [Studies on the action mechanism of procarbazine (Natulan)].

Authors:  A Rutishauser; W Bollag
Journal:  Experientia       Date:  1967-03-15

5.  [On the cytosic action of N-methyl-N-beta-chloraethyl-hydrazine and its benzaldehydhydrazone (author's transl)].

Authors:  R Braun; G Wolf
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-06-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.